Open AccessAspirin as an Adjunctive Pharmacologic Therapy Option for COVID-19: Anti-Inflammatory, Antithrombotic, and Antiviral Effects All in One Agent
Author(s) -
Udaya S. Tantry,
Karsten Schrör,
Eliano Pio Navarese,
Young-Hoon Jeong,
Jacek Kubica,
Kevin P. Bliden,
Paul A. Gurbel
Publication year - 2021
Publication title -
journal of experimental pharmacology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.555
H-Index - 12
ISSN - 1179-1454
DOI - 10.2147/jep.s330776
Subject(s) - antithrombotic , medicine , aspirin , covid-19 , adjunctive treatment , intensive care medicine , pharmacology , virology , infectious disease (medical specialty) , disease , outbreak
Pharmacologic therapy options for COVID-19 should include antiviral, anti-inflammatory, and anticoagulant agents. With the limited effectiveness, currently available virus-directed therapies may have a substantial impact on global health due to continued reports of mutant variants affecting repeated waves of COVID-19 around the world.